Acelyrin, Inc. (SLRN)
USD 2.49
(-3.68%)
USD 2.49
(-3.68%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -216.9 Million USD | 22.13% |
| 2022 | -278.55 Million USD | -172.45% |
| 2021 | -102.24 Million USD | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q1 | -263.36 Million USD | -21.42% |
| 2024 Q2 | -127.14 Million USD | 51.72% |
| 2023 Q3 | -380.48 Million USD | 31.43% |
| 2023 FY | -216.9 Million USD | 22.13% |
| 2023 Q4 | -216.9 Million USD | 42.99% |
| 2023 Q2 | -554.86 Million USD | -92.74% |
| 2023 Q1 | -287.87 Million USD | -3.35% |
| 2022 Q1 | 102.24 Million USD | 0.0% |
| 2022 FY | -278.55 Million USD | -172.45% |
| 2022 Q4 | -278.55 Million USD | 0.0% |
| 2021 FY | -102.24 Million USD | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| AbCellera Biologics Inc. | -55.94 Million USD | -287.742% |
| Alkermes plc | -166.73 Million USD | -30.085% |
| Agenus Inc. | 274.13 Million USD | 179.122% |
| Alnylam Pharmaceuticals, Inc. | 1.86 Billion USD | 111.599% |
| Aptorum Group Limited | 1.35 Million USD | 16083.467% |
| Ardelyx, Inc. | 34.51 Million USD | 728.486% |
| Arrowhead Pharmaceuticals, Inc. | 4.28 Million USD | 5167.827% |
| Bicycle Therapeutics plc | -481.46 Million USD | 54.95% |
| BioXcel Therapeutics, Inc. | 36.16 Million USD | 699.793% |
| ChromaDex Corporation | -24.04 Million USD | -801.959% |
| Chimerix, Inc. | -25.51 Million USD | -750.033% |
| Corbus Pharmaceuticals Holdings, Inc. | 6.96 Million USD | 3212.81% |
| Caribou Biosciences, Inc. | -23.67 Million USD | -816.092% |
| CRISPR Therapeutics AG | -150.84 Million USD | -43.792% |
| Precision BioSciences, Inc. | -85.41 Million USD | -153.955% |
| Dyadic International, Inc. | -6.37 Million USD | -3300.747% |
| Eton Pharmaceuticals, Inc. | -15.93 Million USD | -1261.344% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2929.785% |
| Lantern Pharma Inc. | -21.7 Million USD | -899.402% |
| HOOKIPA Pharma Inc. | -110.53 Million USD | -96.227% |
| Inhibikase Therapeutics, Inc. | -8.54 Million USD | -2438.904% |
| Incyte Corporation | -3.17 Billion USD | 93.169% |
| IO Biotech, Inc. | -140.69 Million USD | -54.161% |
| Jaguar Health, Inc. | 29.39 Million USD | 837.991% |
| Novavax, Inc. | -298.29 Million USD | 27.285% |
| Janux Therapeutics, Inc. | 5.33 Million USD | 4164.137% |
| Opthea Limited | 28.15 Million USD | 870.322% |
| Ligand Pharmaceuticals Incorporated | -16.78 Million USD | -1191.935% |
| ContextLogic Inc. | -232 Million USD | 6.507% |
| MiMedx Group, Inc. | -33.9 Million USD | -539.813% |
| Pyxis Oncology, Inc. | 10.19 Million USD | 2227.543% |
| TransCode Therapeutics, Inc. | -2.31 Million USD | -9261.263% |
| NextCure, Inc. | -6.47 Million USD | -3248.819% |
| Ocuphire Pharma, Inc. | -50.5 Million USD | -329.502% |
| Oncternal Therapeutics, Inc. | -6.37 Million USD | -3300.266% |
| Outlook Therapeutics, Inc. | 12.16 Million USD | 1883.263% |
| Vaxcyte, Inc. | -368.22 Million USD | 41.095% |
| PDS Biotechnology Corporation | -32.7 Million USD | -563.131% |
| Madrigal Pharmaceuticals, Inc. | 17.27 Million USD | 1355.371% |
| Pharming Group N.V. | 109.8 Million USD | 297.537% |
| Pieris Pharmaceuticals, Inc. | -17.39 Million USD | -1146.856% |
| Avidity Biosciences, Inc. | -175.23 Million USD | -23.782% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1071.192% |
| Reviva Pharmaceuticals Holdings, Inc. | -18.51 Million USD | -1071.192% |
| Sangamo Therapeutics, Inc. | -7.1 Million USD | -2954.972% |
| Sol-Gel Technologies Ltd. | -5.86 Million USD | -3601.416% |
| Salarius Pharmaceuticals, Inc. | -5.61 Million USD | -3766.18% |
| SELLAS Life Sciences Group, Inc. | -1.72 Million USD | -12481.381% |
| Summit Therapeutics Inc. | 34.67 Million USD | 725.549% |
| Sensei Biotherapeutics, Inc. | -6.8 Million USD | -3088.343% |
| Senti Biosciences, Inc. | 1.74 Million USD | 12565.69% |
| Stoke Therapeutics, Inc. | -184.6 Million USD | -17.494% |
| Syros Pharmaceuticals, Inc. | -77.45 Million USD | -180.052% |
| Alaunos Therapeutics, Inc. | -6.06 Million USD | -3478.077% |
| Telomir Pharmaceuticals, Inc. Common Stock | 99.76 Thousand USD | 217505.206% |
| Entrada Therapeutics, Inc. | 628 Thousand USD | 34638.694% |
| VistaGen Therapeutics, Inc. | -117.04 Million USD | -85.314% |
| Wave Life Sciences Ltd. | -168.23 Million USD | -28.93% |
| Sorrento Therapeutics, Inc. | 110.87 Million USD | 295.637% |
| TRACON Pharmaceuticals, Inc. | -7.59 Million USD | -2755.49% |
| Barinthus Biotherapeutics plc | -129.11 Million USD | -67.993% |
| Psyence Biomedical Ltd. | 6.89 Million USD | 3245.985% |
| Phathom Pharmaceuticals, Inc. | -242.36 Million USD | 10.505% |
| Immix Biopharma, Inc. | -17.5 Million USD | -1138.753% |
| Keros Therapeutics, Inc. | -316.7 Million USD | 31.512% |
| MEI Pharma, Inc. | -3.7 Million USD | -5754.332% |
| Windtree Therapeutics, Inc. | 12.51 Million USD | 1833.698% |
| Xeris Biopharma Holdings, Inc. | 161.74 Million USD | 234.104% |
| Rigel Pharmaceuticals, Inc. | 27.79 Million USD | 880.423% |
| Fortress Biotech, Inc. | 7.66 Million USD | 2929.785% |
| Precigen, Inc. | -481 Thousand USD | -44994.179% |
| Clearside Biomedical, Inc. | 14.08 Million USD | 1640.395% |
| AlloVir, Inc. | -62.69 Million USD | -245.982% |
| C4 Therapeutics, Inc. | -55.61 Million USD | -290.015% |
| Fate Therapeutics, Inc. | 61.66 Million USD | 451.738% |
| ImmuCell Corporation | 10.99 Million USD | 2073.539% |
| IDEAYA Biosciences, Inc. | -154.14 Million USD | -40.713% |
| Onconetix, Inc. | 5.33 Million USD | 4168.378% |
| PureTech Health plc | -167.19 Million USD | -29.729% |
| VYNE Therapeutics Inc. | -30.46 Million USD | -612.091% |
| Elevation Oncology, Inc. | -19.11 Million USD | -1034.549% |
| Kintara Therapeutics, Inc. | -4.9 Million USD | -4318.476% |
| Seer, Inc. | -4.24 Million USD | -5015.637% |
| Verrica Pharmaceuticals Inc. | -24.03 Million USD | -802.371% |
| Innoviva, Inc. | 255.56 Million USD | 184.873% |
| Aadi Bioscience, Inc. | -55.86 Million USD | -288.27% |
| ESSA Pharma Inc. | -33.62 Million USD | -545.13% |
| GlycoMimetics, Inc. | -40.98 Million USD | -429.233% |
| GT Biopharma, Inc. | -1.02 Million USD | -21144.172% |
| Inhibrx Biosciences, Inc. | -67.78 Million USD | -219.996% |
| Akebia Therapeutics, Inc. | 61.25 Million USD | 454.087% |
| Catalyst Pharmaceuticals, Inc. | -134.07 Million USD | -61.773% |
| Longboard Pharmaceuticals, Inc. | -13.85 Million USD | -1465.408% |
| Orchestra BioMed Holdings, Inc. | -28.87 Million USD | -651.257% |
| Alzamend Neuro, Inc. | -75.33 Thousand USD | -287821.788% |
| Rocket Pharmaceuticals, Inc. | -30.86 Million USD | -602.816% |
| Aptose Biosciences Inc. | -8.19 Million USD | -2546.819% |
| ZyVersa Therapeutics, Inc. | -3.12 Million USD | -6831.983% |
| Soligenix, Inc. | -4.95 Million USD | -4280.466% |
| Century Therapeutics, Inc. | 847 Thousand USD | 25708.383% |
| Kura Oncology, Inc. | -20.11 Million USD | -978.154% |
| TScan Therapeutics, Inc. | -40.92 Million USD | -429.988% |
| Intensity Therapeutics, Inc. | -8.39 Million USD | -2482.794% |
| Ocean Biomedical, Inc. | 1.82 Million USD | 12006.658% |
| CytomX Therapeutics, Inc. | -3.19 Million USD | -6684.579% |
| Autolus Therapeutics plc | -186.59 Million USD | -16.24% |
| Mineralys Therapeutics, Inc. | -49.3 Million USD | -339.93% |
| EyePoint Pharmaceuticals, Inc. | -275.79 Million USD | 21.353% |
| Eterna Therapeutics Inc. | 34.26 Million USD | 732.961% |
| Adaptive Biotechnologies Corporation | 164.36 Million USD | 231.962% |
| GRI Bio, Inc. | -1.79 Million USD | -11990.468% |
| Xenetic Biosciences, Inc. | -8.98 Million USD | -2314.582% |
| Tenaya Therapeutics, Inc. | -33.25 Million USD | -552.203% |
| IGM Biosciences, Inc. | -72.6 Million USD | -198.74% |
| INmune Bio, Inc. | -25.41 Million USD | -753.579% |
| Heron Therapeutics, Inc. | 150.95 Million USD | 243.691% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -328.163% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1234.839% |
| Entero Therapeutics, Inc. | -2.88 Million USD | -7418.494% |
| Milestone Pharmaceuticals Inc. | 38.01 Million USD | 670.572% |
| X4 Pharmaceuticals, Inc. | -41.18 Million USD | -426.655% |
| Atara Biotherapeutics, Inc. | 31.88 Million USD | 780.267% |
| Coherus BioSciences, Inc. | 377.95 Million USD | 157.389% |
| Verastem, Inc. | -37.27 Million USD | -481.853% |
| Abeona Therapeutics Inc. | -9.07 Million USD | -2290.643% |
| Pliant Therapeutics, Inc. | -51.86 Million USD | -318.231% |
| Tonix Pharmaceuticals Holding Corp. | -15.13 Million USD | -1333.122% |
| Histogen Inc. | -7.48 Million USD | -2797.062% |
| Aprea Therapeutics, Inc. | -21.6 Million USD | -903.864% |
| Surrozen, Inc. | -32.66 Million USD | -564.043% |
| Organovo Holdings, Inc. | -1.5 Million USD | -14293.033% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5060.072% |
| Ovid Therapeutics Inc. | 18.96 Million USD | 1243.991% |
| Panbela Therapeutics, Inc. | 2.61 Million USD | 8391.399% |
| CASI Pharmaceuticals, Inc. | 4.15 Million USD | 5319.033% |
| Cadrenal Therapeutics, Inc. Common Stock | -8.38 Million USD | -2487.986% |
| Centessa Pharmaceuticals plc | -43.44 Million USD | -399.293% |
| Hepion Pharmaceuticals, Inc. | -14.57 Million USD | -1387.995% |
| Arcturus Therapeutics Holdings Inc. | -316.78 Million USD | 31.531% |
| BioRestorative Therapies, Inc. | -722.06 Thousand USD | -29939.47% |
| Apollomics, Inc. | -27.39 Million USD | -691.761% |
| Amarin Corporation plc | -191.04 Million USD | -13.538% |
| Mesoblast Limited | 55.96 Million USD | 487.583% |
| Turnstone Biologics Corp. | -14.58 Million USD | -1387.267% |
| Kymera Therapeutics, Inc. | -25.29 Million USD | -757.595% |
| Synaptogenix, Inc. | -28.66 Million USD | -656.775% |
| Tiziana Life Sciences Ltd | -936 Thousand USD | -23073.397% |
| Aurinia Pharmaceuticals Inc. | 48.73 Million USD | 545.094% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -25060.163% |
| Monopar Therapeutics Inc. | -7.26 Million USD | -2885.145% |
| Exelixis, Inc. | -73.05 Million USD | -196.924% |
| Better Therapeutics, Inc. | -860 Thousand USD | -25121.279% |
| Nurix Therapeutics, Inc. | -24.01 Million USD | -803.273% |
| Apellis Pharmaceuticals, Inc. | -241.37 Million USD | 10.137% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 29567.874% |
| Dermata Therapeutics, Inc. | -7.43 Million USD | -2816.094% |
| Aridis Pharmaceuticals, Inc. | 1.25 Million USD | 17396.89% |
| Gritstone bio, Inc. | 39.49 Million USD | 649.261% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -157.908% |
| TNF Pharmaceuticals, Inc. | -2.63 Million USD | -8140.557% |
| Avid Bioservices, Inc. | 169.72 Million USD | 227.794% |
| Insmed Incorporated | 721.62 Million USD | 130.058% |
| Virpax Pharmaceuticals, Inc. | -9.14 Million USD | -2272.726% |
| MediWound Ltd. | -5.32 Million USD | -3975.592% |
| OmniAb, Inc. | 9.2 Million USD | 2456.873% |
| Alector, Inc. | -35.63 Million USD | -508.646% |
| Seres Therapeutics, Inc. | 85.97 Million USD | 352.298% |
| Checkpoint Therapeutics, Inc. | -4.92 Million USD | -4301.441% |
| Viracta Therapeutics, Inc. | 13.23 Million USD | 1738.364% |
| Zai Lab Limited | -775 Million USD | 72.013% |
| Revance Therapeutics, Inc. | 340.55 Million USD | 163.691% |
| Aura Biosciences, Inc. | -21.52 Million USD | -907.679% |
| Lyell Immunopharma, Inc. | -82.48 Million USD | -162.976% |
| Immunic, Inc. | -45.34 Million USD | -378.392% |
| Tarsus Pharmaceuticals, Inc. | -193.21 Million USD | -12.26% |
| Veracyte, Inc. | -203.82 Million USD | -6.417% |
| InMed Pharmaceuticals Inc. | 638.29 Million USD | 133.982% |
| FibroGen, Inc. | 56.76 Million USD | 482.093% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2535.744% |
| Adial Pharmaceuticals, Inc. | -2.82 Million USD | -7572.328% |
| Sonnet BioTherapeutics Holdings, Inc. | -2.07 Million USD | -10376.645% |
| Jazz Pharmaceuticals plc | 4.59 Billion USD | 104.725% |
| Cyclacel Pharmaceuticals, Inc. | -3.34 Million USD | -6392.158% |
| Amylyx Pharmaceuticals, Inc. | -165.96 Million USD | -30.693% |
| TG Therapeutics, Inc. | 17.86 Million USD | 1314.327% |
| Galecto, Inc. | -21.21 Million USD | -922.356% |
| Calithera Biosciences, Inc. | -23.78 Million USD | -811.932% |
| Fortrea Holdings Inc. | 1.56 Billion USD | 113.821% |
| KalVista Pharmaceuticals, Inc. | -24.47 Million USD | -786.331% |
| Aptevo Therapeutics Inc. | -11.5 Million USD | -1784.966% |
| XBiotech Inc. | -200.02 Million USD | -8.439% |
| Jasper Therapeutics, Inc. | -84.1 Million USD | -157.908% |
| Lyra Therapeutics, Inc. | 4.52 Million USD | 4890.261% |
| Foghorn Therapeutics Inc. | -35.26 Million USD | -515.101% |
| Y-mAbs Therapeutics, Inc. | -77.21 Million USD | -180.897% |
| Theravance Biopharma, Inc. | 5.69 Million USD | 3911.334% |
| Ultragenyx Pharmaceutical Inc. | -170.41 Million USD | -27.279% |
| Metagenomi, Inc. Common Stock | -92.37 Million USD | -134.81% |
| Vaxxinity, Inc. | 10.13 Million USD | 2240.772% |
| BioCryst Pharmaceuticals, Inc. | 736.26 Million USD | 129.46% |
| Gain Therapeutics, Inc. | -10.76 Million USD | -1914.413% |
| Cartesian Therapeutics, Inc. | -65.95 Million USD | -228.86% |
| NexImmune, Inc. | -3.13 Million USD | -6821.752% |
| Creative Medical Technology Holdings, Inc. | -3.45 Million USD | -6182.176% |
| Marker Therapeutics, Inc. | -15.11 Million USD | -1335.355% |
| Regeneron Pharmaceuticals, Inc. | -27.1 Million USD | -700.38% |
| Chemomab Therapeutics Ltd. | -8.97 Million USD | -2316.463% |
| Scopus BioPharma Inc. | -124.57 Thousand USD | -174014.389% |
| RAPT Therapeutics, Inc. | -40.57 Million USD | -434.613% |
| Ainos, Inc. | 4.07 Million USD | 5418.951% |
| Pluri Inc. | 22.82 Million USD | 1050.12% |
| Prothena Corporation plc | -608.34 Million USD | 64.346% |
| Adaptimmune Therapeutics plc | -118.75 Million USD | -82.646% |
| Celularity Inc. | 65.19 Million USD | 432.724% |
| Rallybio Corporation | -24.1 Million USD | -799.938% |
| Cue Biopharma, Inc. | -33.81 Million USD | -541.364% |
| MeiraGTx Holdings plc | -40.3 Million USD | -438.194% |
| Omeros Corporation | 331.17 Million USD | 165.495% |
| Humacyte, Inc. | -22.48 Million USD | -864.614% |
| Immunocore Holdings plc | -358.59 Million USD | 39.513% |
| Cocrystal Pharma, Inc. | -24.57 Million USD | -782.616% |
| Cidara Therapeutics, Inc. | -30.9 Million USD | -601.929% |
| Blueprint Medicines Corporation | 702.83 Million USD | 130.861% |
| CalciMedica, Inc. | -5.53 Million USD | -3822.297% |
| Cabaletta Bio, Inc. | -188.22 Million USD | -15.239% |
| Marinus Pharmaceuticals, Inc. | -10.21 Million USD | -2023.585% |
| Scholar Rock Holding Corporation | -40.03 Million USD | -441.756% |
| Sana Biotechnology, Inc. | -33.25 Million USD | -552.281% |
| Pulmatrix, Inc. | -10.41 Million USD | -1982.202% |
| Elicio Therapeutics, Inc. | -5.97 Million USD | -3528.961% |
| Vigil Neuroscience, Inc. | -38.14 Million USD | -468.672% |
| Intellia Therapeutics, Inc. | -111.4 Million USD | -94.703% |
| Adlai Nortye Ltd. American Depositary Shares | -59.94 Million USD | -261.843% |
| Cytokinetics, Incorporated | 642.37 Million USD | 133.766% |
| Eloxx Pharmaceuticals, Inc. | -5.82 Million USD | -3624.936% |
| Nutriband Inc. | -251.65 Thousand USD | -86089.933% |
| Protara Therapeutics, Inc. | -34.11 Million USD | -535.725% |
| Vor Biopharma Inc. | 4.3 Million USD | 5144.256% |
| Roivant Sciences Ltd. | -6.03 Billion USD | 96.406% |
| Evogene Ltd. | -19.63 Million USD | -1004.732% |
| ProKidney Corp. | -56.23 Million USD | -285.701% |
| Applied Therapeutics, Inc. | -48.67 Million USD | -345.642% |
| Hoth Therapeutics, Inc. | -9.23 Million USD | -2248.15% |
| BridgeBio Pharma, Inc. | 1.36 Billion USD | 115.903% |
| CorMedix Inc. | -43.05 Million USD | -403.81% |
| BioLineRx Ltd. | 7.33 Million USD | 3056.693% |
| Tango Therapeutics, Inc. | -27.46 Million USD | -689.743% |
| Galectin Therapeutics Inc. | 46.14 Million USD | 570.026% |
| Atai Life Sciences N.V. | -28.55 Million USD | -659.517% |
| Renovaro Biosciences Inc. | 2.23 Million USD | 9824.285% |
| Aerovate Therapeutics, Inc. | -22.81 Million USD | -850.662% |
| Zentalis Pharmaceuticals, Inc. | 17.73 Million USD | 1323.022% |
| Sagimet Biosciences Inc. | -75.07 Million USD | -188.919% |
| MediciNova, Inc. | -50.78 Million USD | -327.113% |
| Praxis Precision Medicines, Inc. | -78.8 Million USD | -175.24% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -964127.606% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3261.488% |
| Axsome Therapeutics, Inc. | -199.82 Million USD | -8.549% |
| Biomea Fusion, Inc. | -166.57 Million USD | -30.217% |
| PTC Therapeutics, Inc. | -178.97 Million USD | -21.192% |
| Mereo BioPharma Group plc | -51.46 Million USD | -321.425% |
| Cullinan Oncology, Inc. | -94.84 Million USD | -128.694% |
| Syndax Pharmaceuticals, Inc. | -293.75 Million USD | 26.163% |
| Absci Corporation | -72.59 Million USD | -198.773% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4850.394% |
| 4D Molecular Therapeutics, Inc. | -234.43 Million USD | 7.479% |
| Dyne Therapeutics, Inc. | -94.21 Million USD | -130.231% |
| Kiniksa Pharmaceuticals, Ltd. | -95.69 Million USD | -126.658% |
| Ventyx Biosciences, Inc. | -39.07 Million USD | -455.122% |
| Allakos Inc. | -24.97 Million USD | -768.48% |
| Imunon, Inc. | -4.21 Million USD | -5047.381% |
| Fulcrum Therapeutics, Inc. | -14.74 Million USD | -1371.327% |
| Corcept Therapeutics Incorporated | -135.4 Million USD | -60.194% |
| BioAtla, Inc. | -109.01 Million USD | -98.973% |
| NLS Pharmaceutics AG | 736.06 Thousand USD | 29567.874% |
| Bio-Path Holdings, Inc. | -939 Thousand USD | -22999.361% |
| Allogene Therapeutics, Inc. | 11.96 Million USD | 1912.661% |
| Larimar Therapeutics, Inc. | -21.2 Million USD | -922.983% |
| XOMA Corporation | -29 Million USD | -647.941% |
| Kezar Life Sciences, Inc. | -16.56 Million USD | -1209.801% |
| Cara Therapeutics, Inc. | -9.01 Million USD | -2305.756% |
| aTyr Pharma, Inc. | -7.44 Million USD | -2811.841% |
| Aligos Therapeutics, Inc. | -124.63 Million USD | -74.029% |
| Akero Therapeutics, Inc. | -208.16 Million USD | -4.198% |
| Viridian Therapeutics, Inc. | -81.77 Million USD | -165.231% |
| Eliem Therapeutics, Inc. | -92.76 Million USD | -133.825% |
| EyeGate Pharmaceuticals, Inc. | -859.18 Thousand USD | -25145.233% |
| Akari Therapeutics, Plc | -3.84 Million USD | -5541.17% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 13465.231% |
| Halozyme Therapeutics, Inc. | 1.38 Billion USD | 115.708% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -18155.754% |
| UroGen Pharma Ltd. | 4.39 Million USD | 5039.718% |
| Sutro Biopharma, Inc. | 113.48 Million USD | 291.136% |
| ZIVO Bioscience, Inc. | 71.96 Thousand USD | 301513.246% |
| Orgenesis Inc. | 21.78 Million USD | 1095.699% |
| Entera Bio Ltd. | -10.62 Million USD | -1940.672% |
| GH Research PLC | -78.07 Million USD | -177.807% |
| Lisata Therapeutics, Inc. | -22.28 Million USD | -873.183% |
| Reneo Pharmaceuticals, Inc. | -26.65 Million USD | -713.62% |
| Xencor, Inc. | 29.64 Million USD | 831.693% |
| 60 Degrees Pharmaceuticals, Inc. | -1.96 Million USD | -10911.355% |
| Replimune Group, Inc. | 1.41 Million USD | 15461.402% |
| Coeptis Therapeutics Holdings, Inc. | -244.9 Thousand USD | -88465.094% |
| Vanda Pharmaceuticals Inc. | -126.41 Million USD | -71.577% |
| Lexaria Bioscience Corp. | -1.18 Million USD | -18155.754% |
| Portage Biotech Inc. | -4.98 Million USD | -4254.608% |
| Cardio Diagnostics Holdings, Inc. | -22.49 Thousand USD | -964127.606% |
| Olema Pharmaceuticals, Inc. | -66.12 Million USD | -228.035% |
| OncoCyte Corporation | -6.56 Million USD | -3204.937% |
| Qualigen Therapeutics, Inc. | 897.41 Thousand USD | 24269.808% |
| Processa Pharmaceuticals, Inc. | -4.55 Million USD | -4661.194% |
| Purple Biotech Ltd. | -14.13 Million USD | -1434.184% |
| CollPlant Biotechnologies Ltd. | -23.75 Million USD | -813.045% |
| scPharmaceuticals Inc. | -6.54 Million USD | -3214.026% |
| ProMIS Neurosciences, Inc. | -16.69 Million USD | -1199.43% |
| HilleVax, Inc. | -165.48 Million USD | -31.071% |
| NeuroSense Therapeutics Ltd. | -2.53 Million USD | -8446.217% |
| Tharimmune, Inc. | -10.93 Million USD | -1883.503% |
| Genprex, Inc. | -6.73 Million USD | -3119.278% |
| Neumora Therapeutics, Inc. Common Stock | -368.8 Million USD | 41.188% |
| Atossa Therapeutics, Inc. | -88.46 Million USD | -145.199% |
| XTL Biopharmaceuticals Ltd. | -1.4 Million USD | -15382.013% |
| Virios Therapeutics, Inc. | -3.31 Million USD | -6439.238% |
| OKYO Pharma Limited | -826.84 Thousand USD | -26132.512% |
| Savara Inc. | 153 Thousand USD | 141866.667% |
| Curis, Inc. | -23.88 Million USD | -808.038% |
| Daré Bioscience, Inc. | -5.15 Million USD | -4105.249% |
| Carmell Therapeutics Corporation | -776.01 Thousand USD | -27850.985% |
| Titan Pharmaceuticals, Inc. | -6.2 Million USD | -3393.927% |
| Achieve Life Sciences, Inc. | 1.18 Million USD | 18404.051% |
| BeiGene, Ltd. | -2.25 Billion USD | 90.373% |
| Kiromic BioPharma, Inc. | 12.33 Million USD | 1857.937% |
| Revolution Medicines, Inc. Warrant | -608.2 Million USD | 64.337% |
| Protagonist Therapeutics, Inc. | -185.58 Million USD | -16.875% |
| Erasca, Inc. | -37.21 Million USD | -482.822% |
| bluebird bio, Inc. | 108.57 Million USD | 299.78% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -16741.694% |
| BioMarin Pharmaceutical Inc. | 378.74 Million USD | 157.268% |
| DBV Technologies S.A. | -126.98 Million USD | -70.809% |
| Protagenic Therapeutics, Inc. | -1.28 Million USD | -16741.694% |
| Moderna, Inc. | -2.9 Billion USD | 92.539% |
| Vincerx Pharma, Inc. | -10.35 Million USD | -1995.276% |
| Fresh Tracks Therapeutics, Inc. | -10.86 Million USD | -1895.795% |
| Molecular Templates, Inc. | 707 Thousand USD | 30779.349% |
| Acrivon Therapeutics, Inc. Common Stock | -31.37 Million USD | -591.412% |
| Travere Therapeutics, Inc. | 346.6 Million USD | 162.579% |
| Monte Rosa Therapeutics, Inc. | -82.06 Million USD | -164.316% |
| Spruce Biosciences, Inc. | -91.73 Million USD | -136.458% |
| Celldex Therapeutics, Inc. | -32.27 Million USD | -572.109% |
| Cogent Biosciences, Inc. | -34.37 Million USD | -530.972% |
| MacroGenics, Inc. | -66.98 Million USD | -223.808% |
| RenovoRx, Inc. | -1.17 Million USD | -18391.304% |
| Adicet Bio, Inc. | -138.78 Million USD | -56.285% |
| Prime Medicine, Inc. | -27.94 Million USD | -676.289% |
| Aditxt, Inc. | 18.12 Million USD | 1296.978% |
| Adagene Inc. | -87.62 Million USD | -147.529% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5107.22% |
| Quantum-Si incorporated | -118.55 Million USD | -82.953% |
| Maravai LifeSciences Holdings, Inc. | 36 Million USD | 702.425% |
| Acurx Pharmaceuticals, Inc. | -7.47 Million USD | -2802.028% |
| Voyager Therapeutics, Inc. | -48.5 Million USD | -347.14% |
| SciSparc Ltd. | -2.06 Million USD | -10403.777% |
| Vericel Corporation | 1.27 Million USD | 17085.356% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1708.776% |
| Minerva Neurosciences, Inc. | 41 Million USD | 628.977% |
| Generation Bio Co. | 31.44 Million USD | 789.72% |
| Astria Therapeutics, Inc. | -175.36 Million USD | -23.687% |
| Black Diamond Therapeutics, Inc. | -30.92 Million USD | -601.429% |
| Arcutis Biotherapeutics, Inc. | 116.59 Million USD | 286.034% |
| Invivyd, Inc. | -198.47 Million USD | -9.284% |
| Relay Therapeutics, Inc. | -90.27 Million USD | -140.282% |
| Quoin Pharmaceuticals, Ltd. | -2.39 Million USD | -8946.339% |
| Spero Therapeutics, Inc. | -70.79 Million USD | -206.403% |
| Artelo Biosciences, Inc. | -6.82 Million USD | -3078.066% |
| 2seventy bio, Inc. | 181.71 Million USD | 219.364% |
| ADMA Biologics, Inc. | 90.06 Million USD | 340.827% |
| Clene Inc. | 3.34 Million USD | 6594.102% |
| Capricor Therapeutics, Inc. | -9.08 Million USD | -2288.089% |
| Boundless Bio, Inc. Common Stock | -21.51 Million USD | -908.335% |
| GeoVax Labs, Inc. | -6.45 Million USD | -3261.488% |
| Recursion Pharmaceuticals, Inc. | -344.12 Million USD | 36.97% |
| Citius Pharmaceuticals, Inc. | -25.99 Million USD | -734.252% |
| Contineum Therapeutics, Inc. Class A Common Stock | 177.66 Million USD | 222.085% |
| Relmada Therapeutics, Inc. | -4.09 Million USD | -5201.221% |
| Finch Therapeutics Group, Inc. | 5 Million USD | 4436.325% |
| ALX Oncology Holdings Inc. | -5.2 Million USD | -4064.005% |
| Vir Biotechnology, Inc. | -130.3 Million USD | -66.459% |
| Evaxion Biotech A/S | 5.28 Million USD | 4202.693% |
| Ocular Therapeutix, Inc. | -112.56 Million USD | -92.686% |
| Verve Therapeutics, Inc. | -131.27 Million USD | -65.23% |
| Trevena, Inc. | 2.25 Million USD | 9705.979% |
| Surrozen, Inc. | -32.66 Million USD | -564.043% |
| Tyra Biosciences, Inc. | -51.51 Million USD | -321.089% |
| Cingulate Inc. | 3.08 Million USD | 7136.176% |
| Galmed Pharmaceuticals Ltd. | -2.93 Million USD | -7285.189% |
| Unity Biotechnology, Inc. | 7.18 Million USD | 3117.991% |
| Tenax Therapeutics, Inc. | -9.29 Million USD | -2234.493% |
| Terns Pharmaceuticals, Inc. | -79.32 Million USD | -173.443% |
| ACADIA Pharmaceuticals Inc. | -131.45 Million USD | -65.005% |
| Connect Biopharma Holdings Limited | -105.54 Million USD | -105.513% |
| Clearmind Medicine Inc. | -3.94 Million USD | -5401.47% |
| Kronos Bio, Inc. | -36.05 Million USD | -501.606% |
| Bolt Biotherapeutics, Inc. | 9.4 Million USD | 2405.272% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14975.453% |
| Viking Therapeutics, Inc. | -54.25 Million USD | -299.777% |
| Statera Biopharma, Inc. | 14.41 Million USD | 1604.557% |
| ImmunityBio, Inc. | 618.22 Million USD | 135.085% |
| Korro Bio, Inc. | -132.94 Million USD | -63.155% |
| Kineta, Inc. | -4.54 Million USD | -4676.547% |
| BioVie Inc. | -17.73 Million USD | -1123.205% |
| Codexis, Inc. | -43.27 Million USD | -401.266% |
| Celularity Inc. | 65.19 Million USD | 432.724% |
| Crinetics Pharmaceuticals, Inc. | -3.16 Million USD | -6744.525% |
| Celcuity Inc. | 6.78 Million USD | 3297.504% |
| Virax Biolabs Group Limited | -3.36 Million USD | -6345.962% |
| Cibus, Inc. | -8.07 Million USD | -2585.108% |
| Eledon Pharmaceuticals, Inc. | -4.22 Million USD | -5028.943% |
| eFFECTOR Therapeutics, Inc. | 4.57 Million USD | 4846.236% |
| IN8bio, Inc. | -16.38 Million USD | -1223.467% |
| Kodiak Sciences Inc. | -103.87 Million USD | -108.812% |
| Annexon, Inc. | -193.75 Million USD | -11.947% |
| Adverum Biotechnologies, Inc. | 36 Thousand USD | 602608.333% |
| Assembly Biosciences, Inc. | -17.49 Million USD | -1139.517% |
| Avalo Therapeutics, Inc. | -3.51 Million USD | -6074.295% |
| Ionis Pharmaceuticals, Inc. | 1.05 Billion USD | 120.574% |
| Eyenovia, Inc. | 1.25 Million USD | 17332.276% |
| Puma Biotechnology, Inc. | 26.9 Million USD | 906.181% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6588.344% |
| Xilio Therapeutics, Inc. | -33.24 Million USD | -552.399% |
| Arcellx, Inc. | -296.95 Million USD | 26.958% |
| Cardiff Oncology, Inc. | -19.5 Million USD | -1011.981% |
| Enanta Pharmaceuticals, Inc. | -58.87 Million USD | -268.413% |
| Regulus Therapeutics Inc. | -20.72 Million USD | -946.476% |
| Moolec Science SA | 117.61 Thousand USD | 184516.236% |
| Acumen Pharmaceuticals, Inc. | -38.39 Million USD | -464.866% |
| Geron Corporation | 14.76 Million USD | 1569.433% |
| LAVA Therapeutics N.V. | -37.91 Million USD | -472.032% |
| Royalty Pharma plc | 5.65 Billion USD | 103.833% |
| Atea Pharmaceuticals, Inc. | -141.42 Million USD | -53.374% |
| Greenwich LifeSciences, Inc. | -6.98 Million USD | -3003.303% |
| TFF Pharmaceuticals, Inc. | -5.36 Million USD | -3944.54% |
| Mersana Therapeutics, Inc. | -140.73 Million USD | -54.126% |
| Humacyte, Inc. | -22.48 Million USD | -864.614% |
| Structure Therapeutics Inc. | -124.33 Million USD | -74.445% |
| 89bio, Inc. | -289.05 Million USD | 24.961% |
| PMV Pharmaceuticals, Inc. | -25.24 Million USD | -759.294% |
| Avenue Therapeutics, Inc. | -1.78 Million USD | -12065.059% |
| Genelux Corporation | -6.89 Million USD | -3043.977% |
| Trevi Therapeutics, Inc. | -31.05 Million USD | -598.358% |
| Lexicon Pharmaceuticals, Inc. | 83.59 Million USD | 359.456% |
| Notable Labs, Ltd. | -9.77 Million USD | -2118.73% |
| Liquidia Corporation | -80.17 Million USD | -170.534% |
| Mustang Bio, Inc. | -3.73 Million USD | -5705.755% |
| Immunovant, Inc. | -635.22 Million USD | 65.854% |
| Quantum-Si incorporated | -118.55 Million USD | -82.953% |
| Arbutus Biopharma Corporation | -17.56 Million USD | -1134.929% |
| DiaMedica Therapeutics Inc. | -4.14 Million USD | -5135.409% |
| Vera Therapeutics, Inc. | 8.02 Million USD | 2802.168% |
| Acasti Pharma Inc. | -23 Million USD | -842.852% |
| MiNK Therapeutics, Inc. | -3.36 Million USD | -6341.587% |
| Pasithea Therapeutics Corp. | -16.24 Million USD | -1234.839% |
| Xenon Pharmaceuticals Inc. | -137.74 Million USD | -57.473% |
| Elevai Labs, Inc. Common Stock | -3.11 Million USD | -6860.135% |
| NeuroBo Pharmaceuticals, Inc. | -22.23 Million USD | -875.634% |
| Tempest Therapeutics, Inc. | -18.56 Million USD | -1068.092% |
| Soleno Therapeutics, Inc. | -169.27 Million USD | -28.134% |
| PepGen Inc. | -60.67 Million USD | -257.513% |
| Moleculin Biotech, Inc. | -22.97 Million USD | -844.042% |
| United Therapeutics Corporation | -507.7 Million USD | 57.277% |
| Nuvectis Pharma, Inc. | -19.12 Million USD | -1034.074% |
| Solid Biosciences Inc. | -47.75 Million USD | -354.247% |
| BriaCell Therapeutics Corp. | -862.08 Thousand USD | -25060.163% |
| Immuneering Corporation | -54.94 Million USD | -294.779% |
| Lixte Biotechnology Holdings, Inc. | -4.2 Million USD | -5060.072% |
| Silo Pharma, Inc. | -3.52 Million USD | -6054.485% |
| Belite Bio, Inc | -87.27 Million USD | -148.54% |
| XOMA Corporation | -29 Million USD | -647.941% |
| ARS Pharmaceuticals, Inc. | -70.69 Million USD | -206.807% |
| Bionomics Limited | 227 Million USD | 195.548% |
| Apogee Therapeutics, Inc. | -116.28 Million USD | -86.532% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8463.087% |
| uniQure N.V. | -102.95 Million USD | -110.686% |
| Cassava Sciences, Inc. | -121.13 Million USD | -79.057% |
| Estrella Immunopharma, Inc. | -4.16 Million USD | -5107.22% |
| Poseida Therapeutics, Inc. | 40.95 Million USD | 629.665% |
| Forte Biosciences, Inc. | -11.96 Million USD | -1713.419% |
| Anebulo Pharmaceuticals, Inc. | -3.09 Million USD | -6909.986% |
| Enlivex Therapeutics Ltd. | 106 Thousand USD | 204725.472% |
| Conduit Pharmaceuticals Inc. | -3.24 Million USD | -6588.344% |
| SeaStar Medical Holding Corporation | 8.9 Million USD | 2535.744% |
| FibroBiologics, Inc. Common Stock | -7.41 Million USD | -2824.798% |
| Altimmune, Inc. | -134.48 Million USD | -61.282% |
| Amicus Therapeutics, Inc. | 198.06 Million USD | 209.511% |
| Alpha Tau Medical Ltd. | -2.53 Million USD | -8463.087% |
| Compugen Ltd. | -12.9 Million USD | -1580.897% |
| Peak Bio, Inc. | 10.34 Million USD | 2197.676% |
| Zevra Therapeutics, Inc. | -283 Thousand USD | -76544.17% |
| Benitec Biopharma Inc. | -50.58 Million USD | -328.815% |
| Spyre Therapeutics, Inc. | -104.33 Million USD | -107.885% |
| NKGen Biotech, Inc. Common Stock | 19.64 Million USD | 1204.113% |
| Zura Bio Limited | -99.8 Million USD | -117.325% |
| PolyPid Ltd. | 6.17 Million USD | 3615.446% |
| Aileron Therapeutics, Inc. | 74.12 Million USD | 392.638% |
| NKGen Biotech, Inc. Warrants | 19.64 Million USD | 1204.113% |
| Instil Bio, Inc. | 75.35 Million USD | 387.83% |
| argenx SE | -2.02 Billion USD | 89.309% |
| Immunome, Inc. | -97.02 Million USD | -123.545% |
| Compass Therapeutics, Inc. | -22.49 Million USD | -864.228% |
| Verona Pharma plc | -220.44 Million USD | 1.606% |
| enGene Holdings Inc. Warrants | -71.74 Million USD | -202.333% |
| Shattuck Labs, Inc. | -121.42 Million USD | -78.633% |
| CervoMed Inc. | -7.79 Million USD | -2683.361% |
| LENZ Therapeutics, Inc. | -185.49 Million USD | -16.929% |
| Plus Therapeutics, Inc. | -4.37 Million USD | -4860.05% |
| Dianthus Therapeutics, Inc. | -131.73 Million USD | -64.645% |
| Moolec Science SA | 117.61 Thousand USD | 184516.236% |
| Enveric Biosciences, Inc. | -2.28 Million USD | -9380.122% |
| Inovio Pharmaceuticals, Inc. | 15.89 Million USD | 1464.309% |
| AnaptysBio, Inc. | -18.15 Million USD | -1094.992% |
| Design Therapeutics, Inc. | -18.15 Million USD | -1095.058% |
| Leap Therapeutics, Inc. | -70.38 Million USD | -208.184% |
| NeurAxis, Inc. | 145.7 Thousand USD | 148969.595% |
| Seelos Therapeutics, Inc. | 11.23 Million USD | 2031.116% |
| Lumos Pharma, Inc. | -28.49 Million USD | -661.25% |
| Achilles Therapeutics plc | -126.92 Million USD | -70.892% |
| enGene Holdings Inc. Common Stock | -71.74 Million USD | -202.333% |
| 180 Life Sciences Corp. | -655.73 Thousand USD | -32978.096% |
| Opiant Pharmaceuticals, Inc. | -20.77 Million USD | -944.117% |
| CERo Therapeutics Holdings, Inc. | 1.45 Million USD | 14975.453% |
| Nutriband Inc. | -251.65 Thousand USD | -86089.933% |
| ORIC Pharmaceuticals, Inc. | -13.17 Million USD | -1546.823% |
| CG Oncology, Inc. Common stock | -7.44 Million USD | -2815.363% |
| Fractyl Health, Inc. Common Stock | 340.19 Million USD | 163.758% |
| Rani Therapeutics Holdings, Inc. | 23.73 Million USD | 1013.853% |
| MoonLake Immunotherapeutics | -447.47 Million USD | 51.527% |
| Palisade Bio, Inc. | -12.06 Million USD | -1698.085% |
| Tourmaline Bio, Inc. | -140.31 Million USD | -54.587% |
| Beam Therapeutics Inc. | -262.72 Million USD | 17.44% |
| Neurogene Inc. | -131.95 Million USD | -64.376% |
| Mirum Pharmaceuticals, Inc. | 21.81 Million USD | 1094.238% |
| AEON Biopharma, Inc. | -4.88 Million USD | -4344.734% |
| CARGO Therapeutics, Inc. Common Stock | -377.19 Million USD | 42.495% |
| Sesen Bio, Inc. | -112.55 Million USD | -92.712% |
| Enliven Therapeutics, Inc. | -99.86 Million USD | -117.207% |
| Kiora Pharmaceuticals, Inc. | -2.34 Million USD | -9138.591% |
| Iovance Biotherapeutics, Inc. | -39.02 Million USD | -455.791% |
| Taysha Gene Therapies, Inc. | -83.28 Million USD | -160.444% |
| Athira Pharma, Inc. | -88.99 Million USD | -143.714% |
| Vaccinex, Inc. | -1.28 Million USD | -16740.295% |
| HCW Biologics Inc. | 2.85 Million USD | 7692.846% |
| XOMA Corporation | -29 Million USD | -647.941% |
| Nektar Therapeutics | 210.24 Million USD | 203.169% |
| Arvinas, Inc. | -313.8 Million USD | 30.879% |
| Tevogen Bio Holdings Inc. | 1.62 Million USD | 13465.231% |
| Merus N.V. | -192.88 Million USD | -12.453% |
| Omega Therapeutics, Inc. | 59.98 Million USD | 461.595% |
| Quince Therapeutics, Inc. | -6.93 Million USD | -3026.304% |
| Rezolute, Inc. | -68.16 Million USD | -218.189% |
| Clene Inc. | 3.34 Million USD | 6594.102% |
| Indaptus Therapeutics, Inc. | -13.18 Million USD | -1544.824% |
| BeyondSpring Inc. | -13.75 Million USD | -1476.903% |
| Synlogic, Inc. | -6.68 Million USD | -3144.622% |
| Allarity Therapeutics, Inc. | 1.13 Million USD | 19227.249% |
| Phio Pharmaceuticals Corp. | -8.45 Million USD | -2465.381% |
| Peak Bio, Inc. | 10.34 Million USD | 2197.676% |
| Werewolf Therapeutics, Inc. | -82.42 Million USD | -163.168% |
| Krystal Biotech, Inc. | -350.23 Million USD | 38.069% |
| Karyopharm Therapeutics Inc. | 124.12 Million USD | 274.746% |
| SpringWorks Therapeutics, Inc. | -168.99 Million USD | -28.348% |
| Lipella Pharmaceuticals Inc. | -3.15 Million USD | -6770.228% |
| MannKind Corporation | 143.89 Million USD | 250.733% |
| Ikena Oncology, Inc. | -109.15 Million USD | -98.709% |
| Cyclerion Therapeutics, Inc. | -7.57 Million USD | -2764.919% |
| Gyre Therapeutics, Inc. | -33.1 Million USD | -555.296% |
| Gossamer Bio, Inc. | 180.35 Million USD | 220.264% |
| CohBar, Inc. | -5.93 Million USD | -3557.273% |
| Cognition Therapeutics, Inc. | -29.74 Million USD | -629.135% |
| NRx Pharmaceuticals, Inc. | 4.56 Million USD | 4850.394% |
| Legend Biotech Corporation | -949.39 Million USD | 77.154% |
| Mural Oncology plc | -255.84 Million USD | 15.22% |
| Biora Therapeutics, Inc. | 32.21 Million USD | 773.298% |
| PaxMedica, Inc. Common Stock | -4.71 Million USD | -4504.532% |
| Disc Medicine, Inc. | -358.28 Million USD | 39.46% |
| Champions Oncology, Inc. | 4.81 Million USD | 4607.544% |
| REGENXBIO Inc. | 54.76 Million USD | 496.04% |
| Ensysce Biosciences, Inc. | -268.9 Thousand USD | -80560.972% |
| Anavex Life Sciences Corp. | -151.02 Million USD | -43.622% |
| Cellectar Biosciences, Inc. | -9.01 Million USD | -2306.823% |
| Edgewise Therapeutics, Inc. | -80.68 Million USD | -168.834% |
| Vaxart, Inc. | -8.24 Million USD | -2531.999% |
| PharmaCyte Biotech, Inc. | -50.17 Million USD | -332.25% |
| Aldeyra Therapeutics, Inc. | -127.16 Million USD | -70.567% |
| Cellectis S.A. | -43.85 Million USD | -394.591% |
| Longeveron Inc. | -2.9 Million USD | -7358.838% |
| Repare Therapeutics Inc. | -107.85 Million USD | -101.101% |
| Sarepta Therapeutics, Inc. | 968.37 Million USD | 122.399% |
| Inozyme Pharma, Inc. | 12 Million USD | 1906.923% |
| Revolution Medicines, Inc. | -608.2 Million USD | 64.337% |
| Nymox Pharmaceutical Corporation | -1.23 Million USD | -17534.39% |
| Third Harmonic Bio, Inc. | -265.11 Million USD | 18.186% |
| ArriVent BioPharma, Inc. Common Stock | -150.07 Million USD | -44.533% |
| AN2 Therapeutics, Inc. | -15.64 Million USD | -1286.227% |
| Anixa Biosciences, Inc. | -740 Thousand USD | -29211.216% |
| Vertex Pharmaceuticals Incorporated | -9.56 Billion USD | 97.732% |
| Denali Therapeutics Inc. | -74.86 Million USD | -189.726% |
| Revelation Biosciences, Inc. | -11.99 Million USD | -1708.776% |
| Veru Inc. | 4.77 Million USD | 4637.749% |
| Corvus Pharmaceuticals, Inc. | -11.24 Million USD | -1828.712% |
| Cingulate Inc. | 3.08 Million USD | 7136.176% |
| Passage Bio, Inc. | 4.58 Million USD | 4830.709% |
| Context Therapeutics Inc. | -14.44 Million USD | -1401.077% |
| Exicure, Inc. | 5.84 Million USD | 3808.378% |
| Day One Biopharmaceuticals, Inc. | -230.37 Million USD | 5.848% |
| Oramed Pharmaceuticals Inc. | -39.57 Million USD | -448.15% |
| Scinai Immunotherapeutics Ltd. | 15.69 Million USD | 1482.34% |
| Rhythm Pharmaceuticals, Inc. | -58.82 Million USD | -268.751% |
| Nuvalent, Inc. | -335.38 Million USD | 35.328% |
| ABVC BioPharma, Inc. | 1.73 Million USD | 12606.364% |
| Carisma Therapeutics, Inc. | -74.48 Million USD | -191.215% |
| Unicycive Therapeutics, Inc. | -8.89 Million USD | -2339.854% |
| OmniAb, Inc. | 9.2 Million USD | 2456.873% |
| Anew Medical, Inc. | 1.43 Million USD | 15241.941% |
| Fennec Pharmaceuticals Inc. | 16.38 Million USD | 1424.052% |
| Lipocine Inc. | -4.75 Million USD | -4461.969% |
| Lexeo Therapeutics, Inc. Common Stock | -109.82 Million USD | -97.493% |
| Nautilus Biotechnology, Inc. | 15.23 Million USD | 1524.089% |
| SAB Biotherapeutics, Inc. | -50.65 Million USD | -328.163% |
| G1 Therapeutics, Inc. | 24.89 Million USD | 971.376% |
| Bellerophon Therapeutics, Inc. | -6.72 Million USD | -3127.243% |
| Sage Therapeutics, Inc. | -65.82 Million USD | -229.505% |
| Ocugen, Inc. | -32.52 Million USD | -566.963% |
| Mind Medicine (MindMed) Inc. | -85.57 Million USD | -153.465% |
| Q32 Bio Inc. | -37.94 Million USD | -471.58% |
| Brainstorm Cell Therapeutics Inc. | -628 Thousand USD | -34438.694% |
| Alumis Inc. Common Stock | -13.52 Million USD | -1503.245% |
| Equillium, Inc. | -22.39 Million USD | -868.663% |
| Kyverna Therapeutics, Inc. | -25.56 Million USD | -748.338% |
| Coya Therapeutics, Inc. | -32.62 Million USD | -564.801% |
| CNS Pharmaceuticals, Inc. | -247.91 Thousand USD | -87390.874% |
| Galera Therapeutics, Inc. | 134.04 Million USD | 261.817% |
| Evelo Biosciences, Inc. | 3.19 Million USD | 6882.458% |
| Comera Life Sciences Holdings, Inc. | 328.44 Thousand USD | 66140.172% |
| Dominari Holdings Inc. | 195 Thousand USD | 111332.308% |
| Edesa Biotech, Inc. | -5.26 Million USD | -4018.221% |
| vTv Therapeutics Inc. | -8.91 Million USD | -2332.466% |
| Bio-Techne Corporation | 267.74 Million USD | 181.01% |
| Agios Pharmaceuticals, Inc. | -16.2 Million USD | -1238.164% |
| Harmony Biosciences Holdings, Inc. | -118.09 Million USD | -83.67% |
| Prelude Therapeutics Incorporated | -8.4 Million USD | -2481.257% |
| Candel Therapeutics, Inc. | -12.65 Million USD | -1614.513% |
| iTeos Therapeutics, Inc. | -245.11 Million USD | 11.511% |
| Nkarta, Inc. | 57.29 Million USD | 478.546% |
| BioCardia, Inc. | 212 Thousand USD | 102412.736% |
| Iterum Therapeutics plc | 13.43 Million USD | 1714.102% |